Dermapharm Holding SE: Preliminary announcement of the publication of quarterly reports and quarterly/ interim statements

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements


05.11.2026 / 14:00 CET/CEST
Preliminary announcement of the publication of quarterly reports and quarterly/interim statements transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.

---

Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Quarterly financial report within the 2nd half-year (Q3)

Language: German
Date of disclosure: November 12, 2026
Address: https://ir.dermapharm.de/de/investor-relations/finanzberichte-praesentationen/

Language: English
Date of disclosure: November 12, 2026
Address: https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/

---

05.11.2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News

---

Language:	English
Company:	Dermapharm Holding SE
	Lil-Dagover-Ring 7
	82031 Grünwald
	Germany
Internet:	ir.dermapharm.de
LEI Code:	5299009F0KNZINQQQK37

End of News	EQS News Service

---

2426594  05.11.2026 CET/CEST